Abstract
Dear Readers, According to several estimates, India currently accounts for about 20% share in the global supply of generic medicines and 62% share of the global demand for vaccines by volume. Vaccines accounted for USD 33 billion or 2% of the global pharmaceutical market in 2019 by value. This share is likely to grow by 64% and increase to USD 54 billion by 2027, as per recent developments and current market research studies. This presents a great opportunity to the Indian pharmaceutical and diagnostics/medical equipment industries and research institutes in general and to the Indian vaccine manufacturers in particular – provided the challenges can be overcome and the serious problems facing the Indian generic manufacturers are bypassed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
